[Influence of phthivazide on the development of immunity in BCG vaccination in experiment]. 1959

E F CHERNUSHENKO

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

E F CHERNUSHENKO
January 1957, Problemy tuberkuleza,
E F CHERNUSHENKO
January 1958, Revista medica de Cordoba,
E F CHERNUSHENKO
January 1955, International journal of Leprosy,
E F CHERNUSHENKO
October 1962, La Semaine des hopitaux: therapeutique,
E F CHERNUSHENKO
January 1969, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
E F CHERNUSHENKO
November 1958, Revista brasileira de tuberculose e doencas toracicas,
E F CHERNUSHENKO
January 1948, Acta paediatrica,
E F CHERNUSHENKO
January 1986, Developments in biological standardization,
E F CHERNUSHENKO
September 1954, Sovetskaia meditsina,
Copied contents to your clipboard!